Elevian Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Elevian General Information

Description

Developer of regenerative medicines designed to halt and reverse the molecular damage caused by aging. The company's medicines engage in targeting root-cause aging mechanisms and develop a medicine that helps to identify blood factors that regulate aging and stimulate the body's natural repair and regeneration mechanisms, enabling users to prevent and treat age-related diseases.

Contact Information

Website
www.elevian.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 90 Bridge Street
  • Suite 100
  • Newton, MA 02458
  • United States
+1 (650)
Primary Industry
Drug Discovery
Vertical(s)
Beauty, Life Sciences
Corporate Office
  • 90 Bridge Street
  • Suite 100
  • Newton, MA 02458
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elevian Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 18-Sep-2026 Completed Out of Business
5. Early Stage VC (Series A) 16-Sep-2021 Completed Generating Revenue
4. Early Stage VC 21-Jul-2020 Completed Generating Revenue
3. Seed Round 07-Sep-2018 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Elevian’s complete valuation and funding history, request access »

Elevian Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Series A
Seed-3
Seed-2
Seed-1 2,108,743 $0.000100 $0.1 $1.24 $1.24 1x $1.24 5.28%
Seed 2,654,866 $0.000100 $0.18 $2.26 $2.26 1x $2.26 6.65%
To view Elevian’s complete cap table history, request access »

Elevian Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of regenerative medicines designed to halt and reverse the molecular damage caused by aging. The company's med
Drug Discovery
Newton, MA
18 As of 2023

San Diego, CA
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elevian Competitors (7)

One of Elevian’s 7 competitors is Biosplice Therapeutics, a Private Equity-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biosplice Therapeutics Private Equity-Backed San Diego, CA
Oisin Biotechnologies Venture Capital-Backed Seattle, WA
Alkahest Formerly VC-backed San Carlos, CA
Verge Labs Venture Capital-Backed San Francisco, CA
Fountain Therapeutics Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 7 competitors. Get the full list »

Elevian Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Elevian Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021273813-A1 Methods and compositions for treating stroke Pending 19-May-2020
CA-3179133-A1 Methods and compositions for treating stroke Pending 19-May-2020
EP-4154001-A1 Methods and compositions for treating stroke Pending 19-May-2020
EP-4154001-A4 Methods and compositions for treating stroke Pending 19-May-2020
US-20230263860-A1 Methods and compositions for treating stroke Pending 19-May-2020 A61K38/1875
To view Elevian’s complete patent history, request access »

Elevian Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elevian Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harvard University University
To view Elevian’s complete investors history, request access »

Ready to get started?

Request a free trial

Elevian FAQs

  • When was Elevian founded?

    Elevian was founded in 2017.

  • Where is Elevian headquartered?

    Elevian is headquartered in Newton, MA.

  • What is the size of Elevian?

    Elevian has 18 total employees.

  • What industry is Elevian in?

    Elevian’s primary industry is Drug Discovery.

  • Is Elevian a private or public company?

    Elevian is a Private company.

  • What is Elevian’s current revenue?

    The current revenue for Elevian is .

  • How much funding has Elevian raised over time?

    Elevian has raised $60.8M.

  • Who are Elevian’s investors?

    Harvard University has invested in Elevian.

  • Who are Elevian’s competitors?

    Biosplice Therapeutics, Oisin Biotechnologies, Alkahest, Verge Labs, and Fountain Therapeutics are some of the 7 competitors of Elevian.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process